Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months (Q33437774)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months |
scientific article |
Statements
1 reference
Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months (English)
1 reference
Jos H Beijnen
Suzanne Leijen
Robin M J M van Geel
Daphne de Jong
Serena Marchetti
Dick Pluim
Shelonitda Rose
Mark A Lee
Tomoko Freshwater
28 October 2016
1 reference